BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 29255727)

  • 1. Early Antimicrobial De-escalation and Stewardship in Adult Hematopoietic Stem Cell Transplantation Recipients: Retrospective Review.
    Snyder M; Pasikhova Y; Baluch A
    Open Forum Infect Dis; 2017; 4(4):ofx226. PubMed ID: 29255727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial de-escalation in adult hematopoietic cell transplantation recipients with febrile neutropenia of unknown origin.
    Petteys MM; Kachur E; Pillinger KE; He J; Copelan EA; Shahid Z
    J Oncol Pharm Pract; 2020 Apr; 26(3):632-640. PubMed ID: 31423947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De-Escalation and Discontinuation of Empirical Antibiotic Treatment in a Cohort of Allogeneic Hematopoietic Stem Cell Transplantation Recipients during the Pre-Engraftment Period.
    Gustinetti G; Raiola AM; Varaldo R; Galaverna F; Gualandi F; Del Bono V; Bacigalupo A; Angelucci E; Viscoli C; Mikulska M
    Biol Blood Marrow Transplant; 2018 Aug; 24(8):1721-1726. PubMed ID: 29578073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating Initial Empiric Therapy for Neutropenic Fever in Vancomycin-Resistant Enterococcus-Colonized Patients.
    Snyder M; Pasikhova Y; Baluch A
    Cancer Control; 2021; 28():10732748211045593. PubMed ID: 34558349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-Course Empiric Antibiotics in Children Undergoing Allogeneic Hematopoietic Cell Transplantation.
    Patel PA; Teherani MF; Xiang Y; Bernardo V; Chandrakasan S; Goggin KP; Haight A; Horwitz E; Liang WH; Parikh SH; Schoettler ML; Spencer K; Stenger E; Watkins B; Williams KM; Leung K; Jaggi P; Qayed M
    Transplant Cell Ther; 2023 Dec; 29(12):778.e1-778.e6. PubMed ID: 37739225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of empiric antibiotic de-escalation in febrile neutropenia.
    Kroll AL; Corrigan PA; Patel S; Hawks KG
    J Oncol Pharm Pract; 2016 Oct; 22(5):696-701. PubMed ID: 26227319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early de-escalation of antibiotic therapy in hospitalized cellular therapy adult patients with febrile neutropenia.
    Lucena M; Gaffney KJ; Urban T; Forbes C; Srinivas P; Majhail NS; Cober E; Mossad SB; Rybicki L; Hamilton BK
    Clin Hematol Int; 2024; 6(1):59-66. PubMed ID: 38817693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic De-Escalation in Critically Ill Patients with Negative Clinical Cultures.
    Roper S; Wingler MJB; Cretella DA
    Pharmacy (Basel); 2023 Jun; 11(3):. PubMed ID: 37368430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De-escalation of empiric broad spectrum antibiotics in hematopoietic stem cell transplant recipients with febrile neutropenia.
    Rearigh L; Stohs E; Freifeld A; Zimmer A
    Ann Hematol; 2020 Aug; 99(8):1917-1924. PubMed ID: 32556455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes Associated with De-escalation of Antibiotics to Target Positive Cultures when Treating Febrile Neutropenia.
    Rainess R; Campbell P; Santamala J; Kubin CJ; Mehta M
    J Pharm Pract; 2024 Apr; 37(2):301-306. PubMed ID: 36201023
    [No Abstract]   [Full Text] [Related]  

  • 11. De-escalation of antimicrobial treatment in neutropenic patients with severe sepsis: results from an observational study.
    Mokart D; Slehofer G; Lambert J; Sannini A; Chow-Chine L; Brun JP; Berger P; Duran S; Faucher M; Blache JL; Saillard C; Vey N; Leone M
    Intensive Care Med; 2014 Jan; 40(1):41-9. PubMed ID: 24231857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early use of imipenem/cilastatin and vancomycin followed by de-escalation versus conventional antimicrobials without de-escalation for patients with hospital-acquired pneumonia in a medical ICU: a randomized clinical trial.
    Kim JW; Chung J; Choi SH; Jang HJ; Hong SB; Lim CM; Koh Y
    Crit Care; 2012 Feb; 16(1):R28. PubMed ID: 22336530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of early de-escalation of empiric antimicrobial therapy in acute leukemia patients with febrile neutropenia at a large academic medical center.
    Ly WJ; Brown EE; Pedretti Z; Auten J; Wilson WS
    J Oncol Pharm Pract; 2023 Mar; 29(2):305-310. PubMed ID: 34927495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of Invasive Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: The Turin Experience.
    Busca A; Cinatti N; Gill J; Passera R; Dellacasa CM; Giaccone L; Dogliotti I; Manetta S; Corcione S; De Rosa FG
    Front Cell Infect Microbiol; 2021; 11():805514. PubMed ID: 35071052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumococcal Urinary Antigen Testing in United States Hospitals: A Missed Opportunity for Antimicrobial Stewardship.
    Schimmel JJ; Haessler S; Imrey P; Lindenauer PK; Richter SS; Yu PC; Rothberg MB
    Clin Infect Dis; 2020 Sep; 71(6):1427-1434. PubMed ID: 31587039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacist recommendations for carbapenem de-escalation in urinary tract infection within an antimicrobial stewardship program.
    Sadyrbaeva-Dolgova S; Aznarte-Padial P; Jimenez-Morales A; Expósito-Ruiz M; Calleja-Hernández MÁ; Hidalgo-Tenorio C
    J Infect Public Health; 2020 Apr; 13(4):558-563. PubMed ID: 31685404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized Trial of Rapid Multiplex Polymerase Chain Reaction-Based Blood Culture Identification and Susceptibility Testing.
    Banerjee R; Teng CB; Cunningham SA; Ihde SM; Steckelberg JM; Moriarty JP; Shah ND; Mandrekar JN; Patel R
    Clin Infect Dis; 2015 Oct; 61(7):1071-80. PubMed ID: 26197846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of De-Escalating Empiric Antimicrobial Agents in Trauma Patients with Indigenous Oral Flora Ventilator-Associated Pneumonia.
    Kaylor DM; Caminiti N; Harbrecht B; McPheeters C; Scherrer LA
    Surg Infect (Larchmt); 2022 Aug; 23(6):597-603. PubMed ID: 35917387
    [No Abstract]   [Full Text] [Related]  

  • 19. Reducing antimicrobial overuse through targeted therapy for patients with community-acquired pneumonia: a study protocol for a cluster-randomized factorial controlled trial (CARE-CAP).
    Deshpande A; Walker R; Schulte R; Pallotta AM; Tereshchenko LG; Hu B; Kadri SS; Klompas M; Rothberg MB
    Trials; 2023 Sep; 24(1):595. PubMed ID: 37716990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Empiric Treatment for Vancomycin-Resistant Enterococcus in Colonized Patients Early after Allogeneic Hematopoietic Stem Cell Transplantation.
    Kamboj M; Cohen N; Huang YT; Kerpelev M; Jakubowski A; Sepkowitz KA; Papanicolaou GA; Seo SK
    Biol Blood Marrow Transplant; 2019 Mar; 25(3):594-598. PubMed ID: 30448456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.